Northern Trust Company of Connecticut’s GenMark Diagnostics, Inc GNMK Stock Holding History

Northern Trust Company of Connecticut’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$73K	Hold	5,463	–	–	﹤0.01%	1907
2013 Q3	$66K	Hold	5,463	–	–	﹤0.01%	1890
2013 Q2	$57K	Buy	+5,463	New	+$75.3K	﹤0.01%	1874

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Northern Trust Company of Connecticut's GNMK Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its GenMark Diagnostics, Inc (GNMK) position steady in Q4 2013 at 5,463 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Northern Trust Company of Connecticut first reported a position in GNMK in Q2 2013 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold GNMK as of Q4 2013.

Northern Trust Company of Connecticut held 5,463 shares of GenMark Diagnostics, Inc worth $73K as of Q4 2013.
Northern Trust Company of Connecticut left its GenMark Diagnostics, Inc share count unchanged in Q4 2013.
GenMark Diagnostics, Inc made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1907 holding.
Northern Trust Company of Connecticut first reported a position in GenMark Diagnostics, Inc in Q2 2013 and has held it in 3 quarters since.
78 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.